Literature DB >> 23514623

Canadian Cancer Risk Management Model: evaluation of cancer control.

William K Evans1, Michael C Wolfson, William M Flanagan, Janey Shin, John Goffin, Anthony B Miller, Keiko Asakawa, Craig Earle, Nicole Mittmann, Lee Fairclough, Jillian Oderkirk, Philippe Finès, Stephen Gribble, Jeffrey Hoch, Chantal Hicks, D Walter R Omariba, Edward Ng.   

Abstract

OBJECTIVES: The aim of this study was to develop a decision support tool to assess the potential benefits and costs of new healthcare interventions.
METHODS: The Canadian Partnership Against Cancer (CPAC) commissioned the development of a Cancer Risk Management Model (CRMM)--a computer microsimulation model that simulates individual lives one at a time, from birth to death, taking account of Canadian demographic and labor force characteristics, risk factor exposures, and health histories. Information from all the simulated lives is combined to produce aggregate measures of health outcomes for the population or for particular subpopulations.
RESULTS: The CRMM can project the population health and economic impacts of cancer control programs in Canada and the impacts of major risk factors, cancer prevention, and screening programs and new cancer treatments on population health and costs to the healthcare system. It estimates both the direct costs of medical care, as well as lost earnings and impacts on tax revenues. The lung and colorectal modules are available through the CPAC Web site (www.cancerview.ca/cancerrriskmanagement) to registered users where structured scenarios can be explored for their projected impacts. Advanced users will be able to specify new scenarios or change existing modules by varying input parameters or by accessing open source code. Model development is now being extended to cervical and breast cancers.

Entities:  

Mesh:

Year:  2013        PMID: 23514623     DOI: 10.1017/S0266462313000044

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  13 in total

1.  Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada.

Authors:  Alexander V Louie; George B Rodrigues; David A Palma; Suresh Senan
Journal:  Oncologist       Date:  2014-06-20

2.  Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada.

Authors:  A J Coldman; N Phillips; J Brisson; W Flanagan; M Wolfson; C Nadeau; N Fitzgerald; A B Miller
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

3.  The OncoSim model: development and use for better decision-making in Canadian cancer control.

Authors:  C L Gauvreau; N R Fitzgerald; S Memon; W M Flanagan; C Nadeau; K Asakawa; R Garner; A B Miller; W K Evans; C M Popadiuk; M Wolfson; A J Coldman
Journal:  Curr Oncol       Date:  2017-12-20       Impact factor: 3.677

4.  Multiple sclerosis in Canada 2011 to 2031: results of a microsimulation modelling study of epidemiological and economic impacts.

Authors:  Nana Amankwah; Ruth Ann Marrie; Christina Bancej; Rochelle Garner; Douglas G Manuel; Ron Wall; Philippe Finès; Julie Bernier; Karen Tu; Kim Reimer
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-02       Impact factor: 3.240

5.  Moving toward the elimination of cervical cancer: modelling the health and economic benefits of increasing uptake of human papillomavirus vaccines.

Authors:  A Smith; N Baines; S Memon; N Fitzgerald; J Chadder; C Politis; E Nicholson; C Earle; H Bryant
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

6.  Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada.

Authors:  C Popadiuk; C L Gauvreau; M Bhavsar; C Nadeau; K Asakawa; W M Flanagan; M C Wolfson; A J Coldman; S Memon; N Fitzgerald; J Lacombe; A B Miller
Journal:  Curr Oncol       Date:  2016-02-29       Impact factor: 3.677

7.  Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration.

Authors:  W K Evans; W M Flanagan; A B Miller; J R Goffin; S Memon; N Fitzgerald; M C Wolfson
Journal:  Curr Oncol       Date:  2016-06-09       Impact factor: 3.677

8.  Cerebral palsy in Canada, 2011-2031: results of a microsimulation modelling study of epidemiological and cost impacts.

Authors:  Nana Amankwah; Maryam Oskoui; Rochelle Garner; Christina Bancej; Douglas G Manuel; Ron Wall; Philippe Finès; Julie Bernier; Karen Tu; Kim Reimer
Journal:  Health Promot Chronic Dis Prev Can       Date:  2020-02       Impact factor: 3.240

9.  Alzheimer's and other dementias in Canada, 2011 to 2031: a microsimulation Population Health Modeling (POHEM) study of projected prevalence, health burden, health services, and caregiving use.

Authors:  Douglas G Manuel; Rochelle Garner; Philippe Finès; Christina Bancej; William Flanagan; Karen Tu; Kim Reimer; Larry W Chambers; Julie Bernier
Journal:  Popul Health Metr       Date:  2016-11-03

10.  The Population Health Model (POHEM): an overview of rationale, methods and applications.

Authors:  Deirdre A Hennessy; William M Flanagan; Peter Tanuseputro; Carol Bennett; Meltem Tuna; Jacek Kopec; Michael C Wolfson; Douglas G Manuel
Journal:  Popul Health Metr       Date:  2015-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.